Recently, several case reports have published on incidental findings of histologically confirmed PDAC in patients undergoing prostate-specific membrane antigen (PSMA-) targeted PET imaging for the staging of prostate cancer [16–19]. This evidence concerns the gene FOLH1 and Familial prostate cancer.